Aspiriant LLC Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$267M |
| 2 |
iShares Core 60/40 Balanced Allocation ETF
AOR
|
+$59.2M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$47.8M |
| 4 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$31.2M |
| 5 |
Dimensional US Marketwide Value ETF
DFUV
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leidos
LDOS
|
+$14.6M |
| 2 |
Saic
SAIC
|
+$7.13M |
| 3 |
iShares Core Moderate Allocation ETF
AOM
|
+$4.33M |
| 4 |
Vanguard Small-Cap Value ETF
VBR
|
+$4.22M |
| 5 |
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
|
+$2.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.94% |
| 2 | Financials | 1.93% |
| 3 | Communication Services | 1.27% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Staples | 0.53% |
Similar funds
Aspiriant LLC's Q2 2022 Portfolio in Review
As of Q2 2022, Aspiriant LLC held 297 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Aspiriant LLC deployed $528M of net new capital in Q2 2022, opening 23 new positions and adding to 108 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 745,894 shares worth $23.6M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, down from 9.5% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was iShares Core Moderate Allocation ETF, an estimated $4.33M trimmed.
- Aspiriant LLC's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 745,894 shares worth $23.6M.
- Aspiriant LLC added most to Vanguard Tax-Exempt Bond Index Fund in Q2 2022, an estimated $267M increase.
- Aspiriant LLC's biggest Q2 2022 reduction was iShares Core Moderate Allocation ETF, cutting an estimated $4.33M.
- Aspiriant LLC fully exited Leidos in Q2 2022, selling an estimated $14.6M.
- Aspiriant LLC's ten largest holdings make up 62% of its $2.07B portfolio in Q2 2022.
- Aspiriant LLC opened 23 new positions and closed 23 in Q2 2022.
- Aspiriant LLC's portfolio value rose 14% quarter-over-quarter to $2.07B.
Based on Aspiriant LLC's 13F filing for Q2 2022, filed 25 Jul 2022.